TXNIP contributes to HIV-1 transcriptional competence and inducible reactivation through an EZH2-ETV1 regulatory pathway
Year: 2026
Type: article
Abstract: Persistent human immunodeficiency virus type 1 (HIV-1) latency remains a major barrier to durable remission, yet the host pathways that regulate proviral transcriptional competence and inducible reactivation remain incompletely defined. Thioredoxin-interacting protein (TXNIP) is a glucose-responsive host factor, but its role in HIV-1 transcription and latency regulation has not been established. Here, we provide evidence that TXNIP supports HIV-1 long terminal repeat (LTR)-driven transcription, productive replication, and latency reversal. Genetic depletion of TXNIP reduced LTR reporter activity, nascent viral transcripts, virus production, and latency-reversing agent (LRA)-induced reactivation across reporter-based, productive-infection, chronically infected, latency, primary-cell, and ex vivo models, whereas TXNIP overexpression enhanced viral transcriptional output. Chromatin immunoprecipitation (ChIP) further detected TXNIP-associated signals at HIV-1 LTR-containing chromatin in both TZM-bl and Jurkat T-cell contexts, and co-immunoprecipitation (Co-IP) analyses showed that TXNIP associates with BRD4-, CDK9-, and Tat-containing transcriptional complexes, consistent with a cofactor-associated model of TXNIP-linked HIV-1 transcriptional regulation. Mechanistically, our data support an enhancer of zeste homolog 2 (EZH2)-ETS variant transcription factor 1 (ETV1)-TXNIP regulatory axis linking epigenetic repression to HIV-1 transcriptional control. Genetic EZH2 perturbation and pharmacological perturbation of EZH2-associated repression reduced histone H3 lysine 27 trimethylation (H3K27me3) enrichment at the ETV1 promoter, increased ETV1 expression, and enhanced TXNIP promoter activity. ChIP-qPCR and promoter-reporter analyses supported an ETV1-associated regulatory link between EZH2-associated repression and TXNIP expression. Pharmacological perturbation with SRI-37330 suppressed HIV-1 replication, nascent transcription, and inducible reactivation, including in ex vivo CD4+ T cells from antiretroviral therapy (ART)-suppressed individuals; this inhibitory effect was attenuated in TXNIP-depleted cells. Together, these findings identify TXNIP as a host determinant of HIV-1 transcriptional competence and support an EZH2-ETV1-TXNIP regulatory pathway that links epigenetic regulation of TXNIP expression to HIV-1 transcriptional control.
Source: PLoS Pathogens
Authors: Ziyao Wu(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing), Han Zhang(Investigation, Methodology, Visualization, Writing – review & editing), Taizhen Liang(Data curation, Methodology), Yuzai Zhang(Methodology), Muye Xia(Methodology), Chenliang Zhou(Methodology), Yibin Li(Methodology), Jie Peng(Conceptualization, Data curation, Writing – original draft, Writing – review & editing), Shuwen Liu(Conceptualization, Data curation, Writing – review & editing), Lin Li(Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,043
Funders: Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China, National Science and Technology Major Project, National Major Science and Technology Projects of China, Basic and Applied Basic Research Foundation of Guangdong Province
OpenAlex ID: W7234566343
